Notice: Temporary Suspension of New Experiment Creation
We have temporarily disabled the creation of new experiments as we are continuously running out of space. This issue has been impacting both uploads and downloads from FlowRepository. By taking this step, we aim to make downloads of existing data more reliable.
We apologize for the inconvenience and appreciate your understanding as we work on upgrading our hardware and improving the overall solution.
Thank you for your patience.

Download-button_s

Experiment Overview

Repository ID: FR-FCM-Z2JL Experiment name: Transcriptional programming of alveolar macrophages reveals major changes in lipid metabolism in COPD MIFlowCyt score: 18.00%
Primary researcher: Wataru Fujii PI/manager: Joachim Schultze Uploaded by: Wataru Fujii
Experiment dates: 2020-04-08 - Dataset uploaded: Apr 2020 Last updated: Apr 2020
Keywords: None Manuscripts:
Organizations: None
Purpose: Rationale: Immune cells play a major role in the pathogenesis of chronic obstructive pulmonary disease (COPD). Albeit changes in distribution and cellular functions of major immune cells, such as alveolar macrophages (AMs) and neutrophils have been established, we still do not fully understand their transcriptional reprogramming and contribution to the pathophysiology of COPD. Objective: To determine changes in immune cell type distribution, transcriptional reprogramming and lipid metabolism in the bronchoalveolar lavage (BAL) of COPD patients. Methods: Multi-color flow cytometry (MCFC) was applied using most current cell-type-determining markers to BAL samples from 29 controls and 30 COPD patients at different clinical stages. Whole transcriptomes and lipidomes were analyzed in sorted CD45+Lin-HLA-DR+CD66b-Autofluoreschencehi AMs. Measurements and Main Results: Neutrophil, group 1 and group 2 innate lymphoid cell (ILC), but not AM absolute cell numbers were significantly increased in COPD patients. Focusing on AMs as the largest cell type in the alveolar space, we defined global transcriptional reprogramming and detected significant changes between controls and COPD patients in genes involved in lipid metabolism. Based on these findings, lipidomic assessment of a total of 249 lipid species in sorted AMs revealed changes of cholesteryl ester (CE), monoacylglycerols (MAG) and phosphatidylcholines (PC) in a stage-dependent manner.
Conclusion: The combination of MCFC, transcriptomics and lipidomics demonstrated changes in cell type distribution, significant transcriptional reprogramming and disease stage-dependent changes of AM lipid metabolism as a novel hallmark of COPD.
Comments: None
Funding: Wataru Fujii was supported by a fellowship of the Alexander von Humboldt Foundation (JPN-1186019-HFST-P). This work was further supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, SCHU 950/9-1, 639379 & under Germany’s Excellence Strategy – EXC2151 – 390873048) and Sparse2Big, a pilot project within the Helmholtz Association Information & Data Science Incubator.
Quality control: None
Download FCS Files or login and see the dataset in your inbox for further annotation details.